Clinicians from the Waddell Center for Multiple Sclerosis will conduct MS Symposium 2007: Education, Support and Solutions, a free event for patients, caregivers and health care providers, on Saturday, Oct. 6, at the Oasis Conference Center in Loveland. The Waddell Center is an affiliate of UC Physicians and the Neuroscience Institute at University Hospital and the University of Cincinnati (UC).
Iomai Corporation (Nasdaq: IOMI) announced that travelers who received the company’s patch-based travelers’ diarrhea vaccine were significantly less likely to be sickened as compared with travelers who receive a placebo, according to research presented today by Chief Scientific Officer Gregory Glenn, M.D. at a late-breaker presentation during the “Vaccines and Pediatric Infections” session of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy being held in Chicago.
Biopharmaceutical researchers have found a protein in blood they say is linked to all stages of lung cancer but which rarely shows up in the blood of people without the disease. Testing for this protein might help physicians decide whether smokers or others at high risk for lung cancer should be referred for lung imaging, say investigators, who presented their findings today in Atlanta, Georgia at the American Association for Cancer Research’s second International Conference on Molecular Diagnostics in Cancer Therapeutic Development.
Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) announced that its researchers have discovered a monoclonal antibody that is active against H5N1 avian influenza. The studies will be presented at the 5th International Bird Flu Summit scheduled for September 27 and 28 in Las Vegas, Nevada.
Patients are being put at risk because some hospital doctors are not always following warning procedures over known drug allergies, new research launched at the British Pharmaceutical Conference (BPC) in Manchester shows.
Data from two large, open- label studies show patients experienced one-year survival rates above 50 per- cent when treated with ALIMTA(R) (pemetrexed for injection) or ALIMTA-based regimens for malignant pleural mesothelioma (MPM) in both a first-line and second-line setting.
Canadian Prime Minister Stephen Harper announced the final selection of the Board of Directors for the newly created Mental Health Commission of Canada. Speaking at a gathering of international leaders in the mental health field, the Prime Minister said the selection of the new board members, as well as the chairs of the cross-country network of advisory committees, means the Commission is now formally set to launch its activities.
This week, more than eight hundred pathologists from around Europe and the world will take part in a first of its kind, large-scale virtual microscopy slide seminar on the web. The seminar is arranged by the Biomedical Informatics Research Group from the University of Helsinki in conjunction with the 21st European Congress of Pathology, which will be held in Istanbul, Turkey.
Canadian Prime Minister Stephen Harper announced the final selection of the Board of Directors for the newly created Mental Health Commission of Canada.
We often think that high-tech, surgical methods are the best approach when it comes to medical care. But for children born with clubfoot, there is growing, worldwide interest in a low-tech, non-surgical method of treatment that is more effective, less expensive and easier to provide than surgery.